Insights Widest with the analysis, Proactive gives perspectives that others don't.

Braveheart Braveheart's investments all have transformational potential believes company

On 8 July, the company said that it had acquired a 33% stake in Pharm2Farm Limited, a plant...

1 day, 17 hours ago

Robinhood's commission-free share trading a headache for investors or rivals?

Since Robinhood’s launch in the States six years ago, other larger firms have slashed their fees...

2 days, 9 hours ago

Similar but different: Halma and Melrose fly flag for UK industrials

There are not many similarities in what they produce, but both companies long-term track records...

3 days, 8 hours ago
Deep dive

Equals Group brings in finance heavy hitter ahead of expansion moves

Richard Cooper was CFO of gaming giant GVC from 2008 to 2017 and a key part of its acquisitions...

3 days, 13 hours ago

Tales from the Crypto: China joins blockchain arms race, Libra under fire again

A look at some of the recent major events and movements in crypto markets and the wider...

6 days, 16 hours ago


Investor Update: SkinBio signs commercial deal with chemical giant Croda

Headlines from the Proactive UK newsroom. SkinBioTherapeutics (LON:SBTX) has signed a commercial and manufacturing agreement for its Skinbiotix technology with speciality chemical giant Croda.  It is the first major deal for the product with Croda to design and manufacture a new active...

2 days, 16 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.